Repurchase Report of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on the repurchase of the company\'s shares through centralized bidding transactions
Announcement of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on participating in the 2024 Semi-Annual Biological Products Special Group Performance Briefing
Announcement of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for share repurchases
Jiabiyou Biotechnology (Wuhan) Co., Ltd. Investor Activity Record Form for August 27, 2024
Jiabiyou Biotechnology (Wuhan) Co., Ltd. Anti-fraud system (established in August 2024)
Announcement of Resolutions of the 21st Meeting of the Third Board of Directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd.
Jiabiyou Biotechnology (Wuhan) Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Jiabiyou Biotechnology (Wuhan) Co., Ltd.
Announcement of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on the plan to repurchase the company\'s shares through centralized bidding transactions
Special report on the storage and use of funds raised by Jiabiyou Biotechnology (Wuhan) Co., Ltd. for the 2024 semi-year
Announcement of Resolutions of the 20th Meeting of the 3rd Board of Supervisors of Jiabiyou Biotechnology (Wuhan) Co., Ltd.
Announcement of Cabio Biotech (Wuhan) Co., Ltd. on the Proposal of Repurchasing Company Shares by the Company's Chairman, General Manager and Actual Controller.
Announcement Regarding Litigation Progress by Cabio Biotech (Wuhan) Co., Ltd.
Voluntary disclosure announcement from cabio biotech(wuhan) co., ltd. regarding the approval of 2'-fucosyllactose.
Cabio Biotech(Wuhan): Cabio Biotech (Wuhan) Co., Ltd. voluntary disclosure announcement regarding the successful certification of algae oil DHA as a new resource food in the EU.
Cabio Biotech (Wuhan) Co., Ltd. voluntary disclosure announcement regarding the successful certification of algae oil DHA as a new resource food in the EU.
Record of Investor Activity for Cabio Biotech (Wuhan) Co., Ltd. dated July 18, 2024.
Announcement by Cabio Biotech (Wuhan) Co., Ltd. about winning the first-instance lawsuit.
Cabio Biotech (Wuhan) Co., Ltd.'s "Improve Quality and Efficiency and Return" action plan for the year 2024.
Voluntary disclosure announcement of Cabio Biotech (Wuhan) Co., Ltd.'s expected performance growth in the first half of 2024.
No Data
No Data